Meeting
2019 ASCO Annual Meeting
Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis.
Authors
Kelly A. Metcalfe
University of Toronto, Toronto, ON, Canada
Kelly A. Metcalfe , Aletta Poll , Andrea Eisen , Jordan Lerner-Ellis , Steven Narod
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 37, 2019 (suppl; abstr 1577)
DOI
10.1200/JCO.2019.37.15_suppl.1577
Abstract #
1577
Poster Bd #
71
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Examining the prevalence of anxiety and depression in surgical oncology patients: Results of a prospective cohort study.
First Author: Judy Li
Poster
2022 ASCO Quality Care Symposium
Oncologist-reported frequency of managing specific long-term and late effects in breast cancer survivors.
First Author: Eden Brauer
Poster
2021 ASCO Annual Meeting
Impact of patient, tumour and treatment factors on psychosocial outcomes in invasive breast cancer.
First Author: David W Lim
Poster
2019 ASCO Quality Care Symposium
Adherence to breast cancer treatment guidelines according to pathogenic variants in cancer susceptibility genes in a population-based cohort.
First Author: Steven J. Katz